CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results
Portfolio Pulse from
Monogram Technologies Inc. (NASDAQ:MGRM) has released corrected financial results for the full year 2024. The company has completed all supplemental testing and submitted a formal response to the FDA's Additional Information Request. A business update conference call is scheduled for March 12, 2025.
March 12, 2025 | 11:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Monogram Technologies has corrected its 2024 financial results and completed FDA-related testing, which could influence investor confidence. A business update call is scheduled for March 12, 2025.
The correction of financial results and completion of FDA testing are significant events that could positively impact investor sentiment. The upcoming business update call may provide further insights into the company's performance and future plans.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100